Outcome of E2993 patients by protocol-defined and molecular-defined risk assignment. Kaplan-Meier estimates of RFS and OS for patients stratified by their protocol-defined risk: low risk (pLR) and high risk (pHR), and molecular risk: mSR, mIR, and mHR.